Bioactivity of Ginsenosides Rh2 and Rg3 - Delaying Aging and Health Benefits

Description

Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf and Rg1) are the main active substance in our traditional medical herb ginseng. After transformation, the secondary metabolites of ginsenosides, such as F1, F2, Rg3, Rh1, Rh2, Rh3, CY, CM and CK, have much stronger biological activity, which are also called rare ginsenosides.

Rare ginsenosides can be easily absorbed by body, with the effects of promoting sedation and hypnosis, boosting cell differentiation and proliferation, inhibiting tumor progression, lowering blood sugar and enhancing immunity.

Currently, the development time of ginsenosides is relatively short. Only ginsenoside Rg3 has been approved for clinical cancer treatment, while other products can be only used as health care products in the form of functional foods for anti-cancer purposes.

Specification

Appearance

Earth yellow to brown powder，no foreign body visible
Loss on Drying

≤5.0%
Assay(dry basis)Rh2(S/R)

30.0%≤Rh2(S/R)≤40.0%
Pb

≤2.0mg/kg
As

≤1.0mg/kg
Hg

≤0.1mg/kg
Cd

≤0.2mg/kg
Cu

≤20.0mg/kg

Functions

·Promote sexual function and anti aging

·Reduce fatigue and strengthen the body's vitality

·Anti platelet agglutination, prevent cerebral thrombosis

·Anti-radiation, anti-genetic and immune damage

·Protect nerve cells, prevent Alzheimer's disease

·Enhance the immunity of the body against disease invasion

·Prevent cardiovascular diseases by improving myocardial ischemia

·Improve the anti - tumor ability, increase the effect of radiotherapy

and chemotherapy and reduce the toxicity

Application

Beverages

Wine

Drug

Snacks

Health care products

Skincare

Daily chemical product

Functional food

Advantages

·Provide one-stop product solution customization service

·Multiple patents and strict third-party self-inspection

·The first national mass production of ginsenosides by enzymatic synthesis, with pure raw materials, higher conversion rate and higher content, up to 98%

·The unique Bonzyme enzymatic synthesis technology, which can accurately synthesize both S-type and R-type isomers, resulting in stronger activity and precise targeting action

Why Choose Us

As the pioneer of NMN industry, BONTAC is the world's first NMN mass production, China's first KOSHER certified coenzyme production enterprise, with the world's first whole enzyme technology, a total of 180+ international patents, adhere to the whole chain independent innovation research and development, is a stable supplier of more than 1200 enterprises worldwide. The first provincial coenzyme engineering technology research center in China and the only one in Guangdong Province.

Under the supervision of the global authoritative export food safety management system FSSC22000 and the strict and recognized safety substance SELFGRAS safety assessment standard implemented by the US Food and Drug Administration (FDA), BONTAC controls product quality from the front end of production management. Committed to providing customers with high-quality, healthy, safe and reassuring raw material products.